Oh S, Hayashi M, Yamaki K
Prostaglandins Leukot Med. 1986 Apr;22(1):21-33. doi: 10.1016/0262-1746(86)90019-3.
AGEPC-induced vascular permeability increase in the skins of rats, guinea pigs and rabbits was assessed by the leaked dye method, in which the dye was extracted from the skin sites injected with AGEPC after intravenous injection of pontamine sky blue. The activity was the most potent in the dorsal skin of rats and followed by guinea pigs and then rabbits. The vascular effect in rat skin was not affected by pretreatment with mepyramine and methysergide, but partially reduced by indomethacin and significantly suppressed by dexamethasone. Synergism was observed between AGEPC and bradykinin, histamine, 5-hydroxytryptamine, PGE1, PGI2 or PGD2, when each agent was simultaneously injected with AGEPC into the skin. Pleurisy was induced by intrapleural injection of 1 ug of AGEPC into rats. Pleural fluid accumulation and leukocytes migration were observed. The exudate volume was not suppressed by pretreatment with indomethacin but significantly reduced by intravenous injection of CV-3988, a novel antagonist of AGEPC.
采用渗漏染料法评估了AGEPC诱导大鼠、豚鼠和家兔皮肤血管通透性增加的情况,该方法是在静脉注射丽春红天蓝后,从注射了AGEPC的皮肤部位提取染料。其活性在大鼠背部皮肤中最强,其次是豚鼠,然后是家兔。大鼠皮肤中的血管效应不受美吡拉敏和甲基麦角新碱预处理的影响,但吲哚美辛可使其部分降低,地塞米松可显著抑制。当将AGEPC与缓激肽、组胺、5-羟色胺、PGE1、PGI2或PGD2同时注射到皮肤中时,观察到AGEPC与这些物质之间存在协同作用。通过向大鼠胸腔内注射1μg AGEPC诱导胸膜炎。观察到胸腔积液和白细胞迁移。吲哚美辛预处理并未抑制渗出液量,但静脉注射新型AGEPC拮抗剂CV-3988可使其显著减少。